Three enigmatic BioH isoenzymes are programmed in the early stage of mycobacterial biotin synthesis, an attractive anti-TB drug target.
Tuberculosis (TB) is one of the leading infectious diseases of global concern, and one quarter of the world's population are TB carriers. Biotin metabolism appears to be an attractive anti-TB drug target. However, the first-stage of mycobacterial biotin synthesis is fragmentarily understood. He...
Main Authors: | Yongchang Xu, Jie Yang, Weihui Li, Shuaijie Song, Yu Shi, Lihan Wu, Jingdu Sun, Mengyun Hou, Jinzi Wang, Xu Jia, Huimin Zhang, Man Huang, Ting Lu, Jianhua Gan, Youjun Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-07-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1010615 |
Similar Items
-
The opportunistic pathogen Pseudomonas aeruginosa exploits bacterial biotin synthesis pathway to benefit its infectivity.
by: Yu Shi, et al.
Published: (2023-01-01) -
Isoenzyme analysis /
by: 397253 Moss, D. W.
Published: (1979) -
Glycomimetic inhibitors of mycobacterial glycosyltransferases: targeting the TB cell wall.
by: Lucas, R, et al.
Published: (2008) -
Nematode isoenzyme studies and cytogenetics
by: Yong, Hoi Sen, et al.
Published: (1988) -
Nematode isoenzyme studies and cytogenetics
by: Yong, Hoi Sen, et al.
Published: (1988)